Exceptional Response to Cabozantinib in a Patient With Multiply Relapsed Wilms Tumor

JCO Precis Oncol. 2018:2:PO.18.00021. doi: 10.1200/po.18.00021. Epub 2018 Jul 10.
No abstract available